Home
Up
Products
Distributors
Contact Us
an ISO company
an ISO company
Denver, CO October 25, 2005   News Release Index 

William P. Danielczyk, Healthcare and Financial Industry Expert, Joins OrthoNetx, Inc.

OrthoNetx, Inc., a privately-held, Colorado-based leading provider of medical devices for osteoplastic surgery, today announced that William P. Danielczyk, Chairman of Galen Capital Group, LLC and a healthcare industry veteran, has joined the company's Board of Directors as a member.

"Bill's strong track record of success in identifying and advising hot growth companies in the healthcare industry make him an invaluable resource to OrthoNetx and a valued partner," said Terry R. Knapp, President and Chief Executive Officer of OrthoNetx, Inc. "Based on our shared vision for OrthoNetx, he and Galen Capital Group have been sound advisors helping us to garner resources and build exciting strategies for future growth."

Mr. Danielczyk is Chairman of Galen Capital Group, LLC, a merchant banking firm serving mid-market companies, and Chairman of the Board of Cosmeceutical Concepts International, an anti-aging skincare product company. He is also Chairman of the Board of FractionAir, Inc., a publicly-traded fractional jet ownership company. During his career he has also served as CEO with numerous healthcare companies. In his leadership roles within these companies, Mr. Danielczyk has raised substantial capital for firms in both the public and private markets.

"Companies such as OrthoNetx with a solid, proven management team, truly innovative solutions, and significant market opportunity are few and far between," said William P. Danielczyk, Chairman of Galen Capital Group. "I have tremendous respect for Terry and his team and look forward to helping build OrthoNetx into one of the world's leading providers of medical devices."

Prior to founding Galen Capital Group, Mr. Danielczyk was Chairman and CEO of Millennium Health Communications, Inc., a B2B Healthcare technology company and also was the founder and CEO of Ambulatory Healthcare Corporation of America ( AHCA), a comprehensive network of integrated and innovative outpatient healthcare services. During his tenure, AHCA became recognized as an industry leader in providing quality services and Inc. 500 named AHCA one of the fastest growing private companies in America for 1997.

On September 6, 2005 OrthoNetx, Inc., announced it has signed a definitive merger agreement with Eye Dynamics, Inc. ( OTCBB: EYDY, Trade), a leading provider of health and safety products, with Dr. Knapp to lead the merged companies as CEO.

About OrthoNetx, Inc.

OrthoNetx, Inc. designs, develops, manufactures and markets patented, FDA-approved medical devices and systems for osteoplastic surgery and distraction osteogenesis- the practice of generating, forming and molding bone. Physician customers include plastic surgeons, oral and maxillofacial surgeons, otolaryngologists, and orthopedic surgeons who correct deformities and deficiencies of the skeleton caused by errors of birth, trauma, infections and tumors. Osteoplastic surgery is applicable to all areas of the skeleton, including the skull and face, jaws, long bones of the upper and lower extremities, hands, wrists, feet, ankles, and the spine. The privately-held company is headquartered in Superior, CO. For more information visit: www.orthonetx.com.

Safe Harbor for Forward Looking Statements

This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

# # #